Beam Therapeutics Inc. BEAM
- BEAM-301 — Glycogen Storage Disease Type 1a Phase 1
G6PC (2 companies · 2 programs)
Companies with an active program directed at G6PC.
Ultragenyx Pharmaceutical Inc. RARE
- GENGLYCOS — Glycogen Storage Disease Type Ia Approved